SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-100536
Filing Date
2016-05-10
Accepted
2016-05-10 17:10:05
Documents
73
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v438199_10q.htm 10-Q 457137
2 EXHIBIT 31.1 v438199_ex31-1.htm EX-31.1 10556
3 EXHIBIT 31.2 v438199_ex31-2.htm EX-31.2 11176
4 EXHIBIT 32.1 v438199_ex32-1.htm EX-32.1 4748
5 EXHIBIT 32.2 v438199_ex32-2.htm EX-32.2 4706
6 EXHIBIT 99.1 v438199_ex99-1.htm EX-99.1 149419
  Complete submission text file 0001144204-16-100536.txt   6396442

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fbio-20160331.xml EX-101.INS 1449794
8 XBRL TAXONOMY EXTENSION SCHEMA fbio-20160331.xsd EX-101.SCH 62594
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fbio-20160331_cal.xml EX-101.CAL 41828
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fbio-20160331_def.xml EX-101.DEF 404207
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fbio-20160331_lab.xml EX-101.LAB 484860
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fbio-20160331_pre.xml EX-101.PRE 459986
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 161636768
SIC: 2834 Pharmaceutical Preparations